Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOGEN INC. Director's Dealing 2023

Jan 27, 2023

30291_dirs_2023-01-27_85e12521-b03c-4e0b-bc80-bd85eafa4495.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: BIOGEN INC. (BIIB)
CIK: 0000875045
Period of Report: 2022-12-31

Reporting Person: SHERWIN STEPHEN A (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-11-15 Common Stock G 695 Disposed 17778 Direct